Akron Biotech is part of the Advanced Regenerative Manufacturing Institute (ARMI) consortium to develop next-generation manufacturing processes and technologies for cells, tissues and organs. The ARMI will receive nearly $300 million in public-private investment from leading manufacturers, universities, nonprofit organizations and the federal government to develop scalable manufacturing processes for engineered tissues and organs.
StemBioSys Partners with VWR for U.S. and Canadian Distribution
SAN ANTONIO – StemBioSys Inc. announced today that it has entered into an agreement with VWR (NASDAQ: VWR) to distribute and market StemBioSys products.
VWR, the leading global independent provider of product and service solutions to laboratory and production facilities, will be the exclusive distributor for StemBioSys in both the United States and Canada. [Read more…]
Precious Cells Group is First Employer Worldwide to Bank Stem Cells for Employees
First Ever Employer to Store Lifesaving Stem Cells for Employees
Edinburgh, UK, December 7, 2016 – Precious Cells is offering their employees the ultimate employee benefit unlike anything ever seen before. They will cryogenically store employees’ and their loved ones’ stem cells, for free. This means they can be used in treatment for life threatening conditions today, tomorrow and in the future. [Read more…]
U.S. FDA Accepts Biological Industries’ Drug Master File for NutriStem® hPSC Xeno-Free Medium
Recently, Biological Industries (BI) submitted a Drug Master File (DMF) to the U.S. Food and Drug Administration (FDA) for purposes of moving its NutriStem® hPSC XF Medium toward being certified for clinical applications. The product is a defined, xeno-free (XF), serum-free (SF) medium that supports the growth and expansion of human induced pluripotent stem (iPS) and embryonic stem cells (ESCs). [Read more…]
Specialty CRO Kimera Labs to Manufacture Stem Cell Exosomes in Florida
Kimera Labs, a specialty contract research organization (CRO), has announced the launch of a 6,000 sq ft, ISO:9001 certified exosome production facility in Miramar, Florida. As an FDA registered tissue facility, Kimera Labs Miramar will produce tissue specific mesenchymal stem cell (MSC) derived exosomes, as well as its Amnio2x amniotic fluid derived products. Amnio2x can be used for orthopedic, cosmetic and regenerative medicine applications.
Exosomes are small vesicles ranging from 30-100nm in size that are found in nearly all eukaryotic fluids and facilitate a range of important cellular functions. They transfer DNA, RNA, and proteins to other cells, thereby altering the function of the targeted cells. Exosomes are commonly found in blood, urine, saliva, synovial fluid, amniotic fluid, semen, and many other fluids. [Read more…]
- « Previous Page
- Next Page »